These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29089006)

  • 1. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of specialized inpatient admissions for adults with intellectual disability.
    Modi M; McMorris C; Palucka A; Raina P; Lunsky Y
    Am J Intellect Dev Disabil; 2015 Jan; 120(1):46-57. PubMed ID: 25551266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
    Medhekar R; Fujimoto K; Aparasu RR; Bhatara VS; Johnson ML; Alonzo JP; Schwarzwald HL; Chen H
    J Manag Care Spec Pharm; 2019 Jan; 25(1):29-38. PubMed ID: 30589632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prescribing of psychotropic drugs in mental health services in Trinidad.
    Moore S; Jaime LK; Maharajh H; Ramtahal I; Reid S; Ramsewak FS; Maharaj M
    Rev Panam Salud Publica; 2002 Sep; 12(3):207-14. PubMed ID: 12396640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of psychotropic polypharmacy in the treatment of children and adolescents with psychiatric disorders.
    Medhekar R; Aparasu R; Bhatara V; Johnson M; Alonzo J; Schwarzwald H; Chen H
    Res Social Adm Pharm; 2019 Apr; 15(4):395-403. PubMed ID: 29929905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drugs prescription at two regional psychiatric hospitals in northern Nigeria.
    Adeponle AB; Obembe AO; Nnaji F; Adeyemi SO; Suleiman GT
    West Afr J Med; 2008 Apr; 27(2):106-10. PubMed ID: 19025025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
    Kearns MA; Hawley KM
    J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.